European shares ride trade relief rally
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St slips on rising bond yields; Walmart results weigh
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Piper Jaffray Reiterates Overweight on argenx (ARGX) Following Efgartigimod Data
September 24, 2018 7:09 AM EDTPiper Jaffray analyst, Edward Tenthoff, reiterated an Overweight rating and $154.00 price target on argenx SE (NASDAQ: ARGX) following the company's positive Phase II Immune Thrombocytopenia data on efgartigimod. The data showed clean safety and clear efficacy. Tenthoff expects full data at ASH in... More
